raloxifene hydrochloride has been researched along with Parkinson Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bourque, M; Côté, M; Di Paolo, T; Morissette, M; Poirier, AA; Soulet, D | 1 |
1 other study(ies) available for raloxifene hydrochloride and Parkinson Disease
| Article | Year |
|---|---|
Neuroprotective and immunomodulatory effects of raloxifene in the myenteric plexus of a mouse model of Parkinson's disease.
Topics: Animals; Anti-Inflammatory Agents; Benzodioxoles; Cells, Cultured; Cytokines; Disease Models, Animal; Dopaminergic Neurons; Inflammation Mediators; Macrophages; Myenteric Plexus; Neuroprotective Agents; NF-kappa B; Nitric Oxide; Parkinson Disease; Quinolines; Raloxifene Hydrochloride; Receptors, Estrogen; Receptors, G-Protein-Coupled; Selective Estrogen Receptor Modulators | 2016 |